Results 101 to 110 of about 114,540 (260)

Clinical Model‐Informed Precision Dosing Consult Service for Accelerating Personalized Medication in Pediatric Patients

open access: yesClinical Pharmacology &Therapeutics, EarlyView.
Traditional dosing strategies often rely on a “one‐size‐fits‐all” paradigm, assuming an “average” patient with typical demographic and pharmacological characteristics. In reality, this often overlooks existing between‐patient variability and can lead to suboptimal drug exposure or toxicity. This issue is especially pronounced in pediatric patients, who
Zachary L. Taylor   +12 more
wiley   +1 more source

PUFAs and IBD [PDF]

open access: yesInflammatory Bowel Diseases, 2017
Livia, Lindoso   +2 more
openaire   +2 more sources

Patients with Chronic Inflammatory Diseases Can Experience Higher Exposure of Small Molecule Drugs than Healthy Volunteers: An Analysis of Recently Approved Drugs

open access: yesClinical Pharmacology &Therapeutics, EarlyView.
Chronic inflammation has long been known to downregulate the activity of certain cytochrome P450 (CYP) enzymes—the main enzymes responsible for the phase I metabolism of many small molecule drugs—potentially leading to higher exposures in patients with chronic inflammatory diseases compared to healthy volunteers. Neglecting this potential difference in
Johannes Tillil   +6 more
wiley   +1 more source

Prevalence of Medical and Psychiatric Comorbidities in Paediatric ARFID: A Meta‐Analysis

open access: yesEuropean Eating Disorders Review, EarlyView.
ABSTRACT Background Avoidant/Restrictive Food Intake Disorder (ARFID) is increasingly recognized as a complex paediatric feeding and eating disorder associated with significant medical and psychiatric burden. Methods This systematic review and meta‐analysis followed PRISMA guidelines and was prospectively registered in PROSPERO (CRD420251241490 ...
Nuria Blay Borch   +8 more
wiley   +1 more source

Metabolic Nanomedicine Reprograms Mesenchymal Stem Cells for Durable Exosome‐Mediated Immunomodulation

open access: yesExploration, EarlyView.
Prolonged inflammatory stress depletes NAD+ in mesenchymal stem cells, driving functional exhaustion and weakening their survival and immune‐regulating activity. We developed an NAD+‐delivering nanomedicine that restores cellular metabolism and improves therapeutic efficacy in colitis.
Jinfeng Chen   +9 more
wiley   +1 more source

Origin and Function of Monocytes in Inflammatory Bowel Disease

open access: yesJournal of Inflammation Research
Xiping Liao,1,2,* Ji Liu,3,* Xiaolong Guo,1 Ruiping Meng,1 Wei Zhang,1 Jianyun Zhou,1 Xia Xie,1,2 Hongli Zhou1 1Clinical Medical Research Center, the Second Affiliated Hospital, Army Medical University, Chongqing, People’s Republic of China ...
Liao X   +7 more
doaj  

Association of TMAO levels with indicators of ulcerative colitis activity [PDF]

open access: yesCaspian Journal of Internal Medicine
Background: The diagnosis of ulcerative colitis (UC) today is limited to a small number of biomarkers. Trimethylamine-N-oxide (TMAO) is the product of reactions resulting from the degradation of dietary-free choline, phosphatidylcholine, and carnitine ...
Yelena Laryushina   +4 more
doaj  

Standardized Tool for Prophylaxis (SToP) of venous thromboembolism: An asynchronous curriculum to enhance venous thromboembolism prevention in pediatric inflammatory bowel disease. [PDF]

open access: yesJPGN Rep
Abstract Objectives Compared to those without inflammatory bowel disease (IBD), pediatric patients with IBD are at three‐ to sevenfold increased risk for venous thromboembolism (VTE), a complication associated with substantial morbidity and mortality.
Michel HK   +4 more
europepmc   +2 more sources

The research progress in polyethylene oxide polymer electrolytes

open access: yesFlexMat, EarlyView.
Polyethylene oxide (PEO) has become the mainstream matrix material for solid polymer electrolytes (SPEs) due to its excellent lithium salt complexation ability and processability. However, its high crystallinity results in low ionic conductivity at room temperature and difficulty in suppressing lithium dendrite growth, which significantly hinders the ...
Ying Wei   +8 more
wiley   +1 more source

Illuminating point‐of‐care diagnostics with aggregation‐induced emission biosensors

open access: yesFlexMat, EarlyView.
This review highlights the application of aggregation‐induced emission luminogens (AIEgens) in point‐of‐care (POC) diagnostics for disease biomarker detection. It systematically examines a range of biosensing platforms, including lateral flow immunoassays, microfluidic chips, and electrochemiluminescence sensors, alongside their utility in detecting ...
Danni Hu   +3 more
wiley   +1 more source

Home - About - Disclaimer - Privacy